Status:
COMPLETED
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
Lead Sponsor:
Tirang R. Neyestani, Ph.D.
Collaborating Sponsors:
Shahid Beheshti University of Medical Sciences
Conditions:
Overweight
Hypovitaminosis D
Eligibility:
FEMALE
20-50 years
Phase:
NA
Brief Summary
46 eligible overweight women with hypovitaminosis D are assigned to either vitamin D or control group using block randomization method. Vitamin D3 pearl (Zahravi Pharma Co, Tabriz, Iran) containing 50...
Detailed Description
For the randomized controlled clinical trial (RCT), the first fifty eligible women were assigned to either the vitamin D or placebo group using the block randomization method. Each Vitamin D3 pearl (Z...
Eligibility Criteria
Inclusion
- low serum vitamin D level \<30ng/ml
- 25\<BMI\<30 kg/m2
- Age: 20-50
- Free of chronic diseased such as cancer, diabetes, cardiovascular disease, renal diseases, gastrointestinal diseases, no multivitamin supplement intake, no change in weight in the last 3 months
Exclusion
- Getting pregnant during the study
- Suffering from thyroid disorders and other diseases mentioned during the study
- Not taking supplements weekly
Key Trial Info
Start Date :
September 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2022
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT05376865
Start Date
September 29 2021
End Date
February 20 2022
Last Update
May 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratory of Nutrition Research, National Nutrition and Food Technology Research Institute (NNFTRI) and Faculty of Nutrition Science and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Tehran, Iran